Sobi - Swedish Orphan Biovitrum AB (publ) · 1 day ago
Director of Biostatistics
Maximize your interview chances
BiotechnologyGenetics
Insider Connection @Sobi - Swedish Orphan Biovitrum AB (publ)
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Provide highly experienced statistical, scientific and strategic support to the clinical and regulatory strategies across all phases of drug development, in-licensing opportunities, pre-clinical development, marketing activities, other specialised areas and/or line functions (e.g. drug safety, clinical pharm) to maximise the benefit-risk of Sobi products.
Accountable for the overall quality and the timely delivery of the statistical analyses for the assigned products.
Accountable for all statistical aspects within assigned products providing statistical, scientific and strategic expertise to quantify the benefit-risk value and uncertainty of the emerging product profile throughout all phases of the drug development process in compliance with Sobi SOPs and regulatory requirements/guidelines.
Accountable for leading the statistical thinking and contributions to the creation and development of TPP/TPC, Target Label and Clinical Development Plans as well as to the Regulatory and Commercial Strategies for Sobi products.
Provide leadership and project coordination to all statisticians working in the project, including in-house consultants and statisticians at CROs.
Accountable for the statistical content in the CSP and CSR.
Qualified for membership of the Study Document Review Forum (SDRF) and may also participate in in-licensing projects or work in other roles as appropriate.
Responsible for coaching and developing less experienced statisticians.
Provide statistical and strategic input into the establishment of a focused, aligned and achievable Target Product Profile (TPP) and Target Labels.
Provide statistical and strategic input into the design and preparation of the Clinical Development Plan (CDP) ensuring alignment with the TPPs and Target Label.
Provide statistical and strategic input to relevant documents in regulatory submissions, e.g. eCTD.
Take a pro-active role in designing innovative studies and programs, including Go/No Go criterion and associated risk levels, to meet project objectives and regulatory requirements.
Approve and sign CSPs, including the statistical content.
Approve Statistical Analysis Plans for studies and regulatory submissions.
Approve and sign CSRs, including the statistical analysis and clinical interpretation of study data.
Participate in preparing responses to regulatory questions.
Provide statistical and strategic input into other regulatory documentation, e.g. CSP, CSR, IB, PSUR and RMP.
Participate in developing the publication strategy as a member of the publication team.
Contribute to the writing of publications and abstracts, in accordance with the publication strategy for the project, as applicable.
Ensure high quality statistical support for projects through the evaluation of CRO suppliers, and provide input into outsourcing strategy and processes.
Collaborate with internal statisticians to drive best practices and implement new initiatives.
Stay informed of developments in new statistical methodology and statistically related guidelines and regulations through literature review and attendance at workshops and professional meetings.
Contribute to the development of SOPs as relevant.
Participate in the review and approval of study essential documents in the role as a project-independent statistician.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor of Science (BSc) in mathematical statistics, statistics or equivalent.
8 years of experience as a statistician in the pharmaceutical industry
Previous leadership experience from project and/or line management
Extensive experience working in phase II, III and IV programs and/or studies
Extensive experience of clinical program and study design and data analysis in using a variety of designs and complex statistical techniques, with different types of data and issues
Experience of major regulatory submissions and/or previous attendance at meetings with regulatory authorities
Comprehensive knowledge of clinical and pharmaceutical drug development
Sound knowledge of theoretical and applied statistics
Ability to find innovative approaches to trial design and analysis
Sound understanding of the regulatory environment within clinical development
Ability to be the statistical representative from the company at regulatory interactions
Ability to coach less experienced statisticians in all aspects of their role.
Excellent written and oral communication skills
Strategic thinking and influencing skills
Ability to communicate statistical information to non-statisticians
Strong ability to collaborate and contribute in global cross-functional teams
Leadership skills
Excellent writing and oral communication in English
Preferred
Master of Science (MSc) or PhD in mathematical statistics, statistics or equivalent
Experience working in all phases of clinical development
Extensive experience of regulatory submissions and previous attendance at meetings with regulatory authorities in more than one region, e.g. Europe, US, Japan, and China
Experience of collaboration with statisticians and other functions at CROs around out-sourced clinical studies
Benefits
Competitive compensation for your work
Generous time off policy
Summer Fridays
Opportunity to broaden your horizons by attending popular conferences
Emphasis on work/life balance
Collaborative and team-oriented environment
Company
Sobi - Swedish Orphan Biovitrum AB (publ)
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases.
Funding
Current Stage
Public CompanyTotal Funding
$825.99M2024-05-08Post Ipo Debt· $274.92M
2023-08-22Post Ipo Equity· $551.07M
2006-09-15IPO
Leadership Team
Guido Oelkers
Chief Executive Officer
Recent News
Morningstar, Inc.
2024-12-20
News Powered by Cision
2024-12-11
2024-12-10
Company data provided by crunchbase